Part of the highly regarded Diagnostic Pathology series, this updated volume by Drs. Marisa R. Nucci and Esther Oliva is an ideal point-of-care reference for the accurate diagnosis of the full range of nonneoplastic and neoplastic conditions of the female genital tract, including common and uncommon entities. Concise, focused chapters, supported by tables, diagrams, and photographs, keep you up to date with evolving changes in the understanding of the pathobiology of common gynecologic tumors. This revised edition is ideal for pathologists at all levels of experience and training for use as a quick reference and as an efficient review to improve knowledge and skills.
1. Cover image 2. Title page 3. Table of Contents 4. Copyright 5. Dedications 6. Contributing Authors 7. Preface 8. Acknowledgments 9. Sections 10. SECTION 1: VULVA 11. INFLAMMATORY DISORDERS 12. Chapter 1: Lichen Planus 13. Chapter 2: Fixed Drug Eruption 14. Chapter 3: Erythema Multiforme 15. Chapter 4: Plasmacytosis Mucosae (Zoon) 16. Chapter 5: Lichen Sclerosus 17. Chapter 6: Allergic Contact Dermatitis 18. Chapter 7: Psoriasis 19. Chapter 8: Lichen Simplex Chronicus 20. Chapter 9: Foreign Body Granulomas 21. Chapter 10: Verruciform Xanthoma 22. Chapter 11: Crohn Disease 23. Chapter 12: Epidermolytic Hyperkeratosis 24. Chapter 13: Papular Acantholytic Dermatosis 25. Chapter 14: Behçet Disease 26. Chapter 15: Pemphigus 27. Chapter 16: Bullous Pemphigoid 28. Chapter 17: Cicatricial Pemphigoid 29. Chapter 18: Herpes Gestationis 30. Chapter 19: Linear IgA Disease 31. Chapter 20: Herpes Simplex Virus 32. Chapter 21: Syphilis 33. Chapter 22: Chancroid 34. Chapter 23: Molluscum Contagiosum 35. Chapter 24: Dermatophytosis 36. Chapter 25: Candidiasis 37. Chapter 26: Scabetic Infestations 38. Chapter 27: Hidradenitis Suppurativa 39. NONNEOPLASTIC LESIONS 40. Chapter 28: Bartholin and Other Cysts 41. Chapter 29: Endometriosis 42. Chapter 30: Fibroepithelial Stromal Polyp 43. Chapter 31: Massive Edema 44. CUTANEOUS NEOPLASIA 45. Chapter 32: HPV-Related Lesions (Excluding Vulvar Intraepithelial Neoplasia) 46. Chapter 33: Vulvar Intraepithelial Neoplasia 47. Chapter 34: Squamous Cell Carcinoma 48. Chapter 35: Basal Cell Carcinoma 49. Chapter 36: Mucosal Melanotic Macule 50. Chapter 37: Common Melanocytic Nevus 51. Chapter 38: Atypical Nevus of Genital Tract 52. Chapter 39: Malignant Melanoma 53. Chapter 40: Extramammary Paget Disease 54. Chapter 41: Bartholin Gland Carcinoma 55. Chapter 42: Hidradenoma Papilliferum 56. Chapter 43: Fibroadenoma and Phyllodes Tumor 57. Chapter 44: Syringoma 58. Chapter 45: Mixed Tumor 59. Chapter 46: Microcystic Adnexal Carcinoma 60. Chapter 47: Eccrine Spiradenoma 61. Chapter 48: Trichofolliculoma 62. Chapter 49: Trichoepithelioma 63. Chapter 50: Sebaceous Hyperplasia 64. Chapter 51: Sebaceous Carcinoma 65. SOFT TISSUE NEOPLASIA 66. Chapter 52: Angiomyofibroblastoma 67. Chapter 53: Cellular Angiofibroma 68. Chapter 54: Prepubertal Vulval Fibroma 69. Chapter 55: Superficial Angiomyxoma 70. Chapter 56: Deep (Aggressive) Angiomyxoma 71. Chapter 57: Smooth Muscle Tumors 72. Chapter 58: Solitary Fibrous Tumor 73. Chapter 59: Dermatofibrosarcoma Protuberans 74. Chapter 60: Epithelioid Sarcoma 75. Chapter 61: Granular Cell Tumor 76. SECTION 2: VAGINA 77. INFLAMMATORY CONDITIONS 78. Chapter 62: Desquamative Inflammatory Vaginitis 79. Chapter 63: Ligneous Vaginitis 80. Chapter 64: Malakoplakia 81. NONNEOPLASTIC LESIONS 82. Chapter 65: Vaginal Cysts 83. Chapter 66: Adenosis 84. Chapter 67: Polyps 85. Chapter 68: Fallopian Tube Prolapse 86. NEOPLASMS 87. Chapter 69: Vaginal Intraepithelial Neoplasia 88. Chapter 70: Squamous Cell Carcinoma 89. Chapter 71: Adenocarcinomas, Nonclear Cell Type 90. Chapter 72: Clear Cell Carcinoma 91. Chapter 73: Mixed Tumor 92. Chapter 74: Rhabdomyoma 93. Chapter 75: Malignant Melanoma 94. Chapter 76: Yolk Sac Tumor 95. Chapter 77: Secondary Neoplasms 96. SECTION 3: UTERINE CERVIX 97. NONNEOPLASTIC LESIONS 98. Chapter 78: Cervical Infections 99. Chapter 79: Atrophy 100. Chapter 80: Transitional Cell Metaplasia 101. Chapter 81: Immature Squamous Metaplasia 102. Chapter 82: Tubal and Tuboendometrioid Metaplasia 103. Chapter 83: Arias-Stella Reaction 104. Chapter 84: Deciduosis 105. Chapter 85: Endometriosis 106. Chapter 86: Tunnel Clusters 107. Chapter 87: Microglandular Hyperplasia 108. Chapter 88: Deep Glands and Cysts 109. Chapter 89: Endocervical Glandular Hyperplasia (Diffuse and Lobular) 110. Chapter 90: Endocervical Polyp 111. Chapter 91: Ectopic Prostate 112. Chapter 92: Mesonephric Remnants/Hyperplasia 113. Chapter 93: Endocervicosis 114. NEOPLASMS 115. Chapter 94: Squamous Intraepithelial Lesion/Dysplasia 116. Chapter 95: Squamous Cell Carcinoma 117. Chapter 96: Adenocarcinoma In Situ, Including Variants 118. Chapter 97: Usual-Type Adenocarcinoma 119. Chapter 98: Minimal Deviation Adenocarcinoma 120. Chapter 99: Villoglandular Adenocarcinoma 121. Chapter 100: Gastric- and Intestinal-Types Adenocarcinoma, Including Signet Ring Cell Carcinoma 122. Chapter 101: Endometrioid Adenocarcinoma 123. Chapter 102: Clear Cell Adenocarcinoma 124. Chapter 103: Serous Adenocarcinoma 125. Chapter 104: Mesonephric Adenocarcinoma 126. Chapter 105: Adenosquamous Carcinoma, Including Glassy Cell Carcinoma 127. Chapter 106: Adenoid Basal Carcinoma 128. Chapter 107: Adenoid Cystic Carcinoma 129. Chapter 108: Neuroendocrine Tumors 130. Chapter 109: Endocervical-Type Adenomyoma 131. Chapter 110: Müllerian Papilloma 132. Chapter 111: Müllerian Adenosarcoma 133. Chapter 112: Malignant Mixed Müllerian Tumor 134. Chapter 113: Rhabdomyosarcoma 135. Chapter 114: Lymphomas and Leukemias of Lower Genital Tract 136. Chapter 115: Metastatic/Secondary Tumors 137. SECTION 4: UTERINE CORPUS 138. NONNEOPLASTIC LESIONS 139. Chapter 116: Endometritis 140. Chapter 117: Endometrial Metaplasias 141. Chapter 118: Endometrial Polyp 142. NEOPLASMS 143. Chapter 119: Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia 144. Chapter 120: Endometrioid Adenocarcinoma and Variants 145. Chapter 121: Mucinous Adenocarcinoma 146. Chapter 122: Serous Adenocarcinoma 147. Chapter 123: Clear Cell Adenocarcinoma 148. Chapter 124: Squamous Cell Carcinoma 149. Chapter 125: Neuroendocrine Carcinoma 150. Chapter 126: Undifferentiated Carcinoma 151. Chapter 127: Leiomyoma and Variants 152. Chapter 128: Intravenous Leiomyomatosis 153. Chapter 129: Leiomyosarcoma 154. Chapter 130: Perivascular Epithelioid Cell (PEC) Proliferations 155. Chapter 131: Inflammatory Myofibroblastic Tumor 156. Chapter 132: Benign and Low-Grade Endometrial Stromal Tumors 157. Chapter 133: High-Grade Endometrial Stromal Sarcoma 158. Chapter 134: Uterine Tumors Resembling Ovarian Sex Cord Tumors 159. Chapter 135: Undifferentiated Uterine Sarcoma 160. Chapter 136: Adenomatoid Tumor 161. Chapter 137: Endometrioid-Type Adenomyoma 162. Chapter 138: Atypical Polypoid Adenomyoma 163. Chapter 139: Müllerian Adenosarcoma 164. Chapter 140: Malignant Mixed Müllerian Tumor 165. Chapter 141: Rhabdomyosarcoma 166. Chapter 142: Primitive Neuroectodermal Tumor, Peripheral and Central Types 167. Chapter 143: Wilms Tumor 168. Chapter 144: Alveolar Soft Part Sarcoma 169. Chapter 145: Germ Cell Tumors 170. Chapter 146: Lymphoma and Leukemia 171. Chapter 147: Metastatic/Secondary Tumors 172. SECTION 5: FALLOPIAN TUBE AND BROAD LIGAMENT 173. NONNEOPLASTIC LESIONS 174. Chapter 148: Metaplasias 175. Chapter 149: Pseudocarcinomatous Hyperplasia 176. Chapter 150: Salpingitis 177. Chapter 151: Endometriosis 178. NEOPLASMS 179. Chapter 152: Metaplastic Papillary Tumor 180. Chapter 153: Adenomatoid Tumor 181. Chapter 154: Female Adnexal Tumor of Probable Wolffian Origin 182. Chapter 155: Serous Borderline Tumor 183. Chapter 156: Serous Carcinoma, Including Serous Tubal Intraepithelial Carcinoma (STIC) 184. Chapter 157: Endometrioid Adenocarcinoma 185. Chapter 158: Transitional Cell Carcinoma 186. SECTION 6: OVARY 187. NONNEOPLASTIC LESIONS 188. Chapter 159: Follicular Cysts 189. Chapter 160: Stromal Hyperplasia and Hyperthecosis 190. Chapter 161: Pregnancy Luteoma 191. Chapter 162: Hyperreactio Luteinalis 192. Chapter 163: Large Solitary Luteinized Follicle Cyst of Pregnancy 193. Chapter 164: Torsion 194. Chapter 165: Endometriosis and Deciduosis 195. Chapter 166: Massive Edema and Fibromatosis 196. Chapter 167: Autoimmune Oophoritis 197. Chapter 168: Luteinized Thecoma With Sclerosing Peritonitis 198. NEOPLASMS 199. EPITHELIAL TUMORS 200. Chapter 169: Benign Serous Tumors 201. Chapter 170: Serous Borderline Tumor 202. Chapter 171: Low-Grade Serous Adenocarcinoma 203. Chapter 172: High-Grade Serous Adenocarcinoma 204. Chapter 173: Benign Endometrioid Tumors 205. Chapter 174: Endometrioid Borderline Tumor 206. Chapter 175: Endometrioid Adenocarcinoma 207. Chapter 176: Benign Mucinous Tumors 208. Chapter 177: Mucinous Borderline Tumor, Intestinal Type 209. Chapter 178: Mucinous Borderline Tumor, Endocervical Type 210. Chapter 179: Mucinous Adenocarcinoma 211. Chapter 180: Mucinous Cystic Tumor With Mural Nodules 212. Chapter 181: Borderline Clear Cell Adenofibroma 213. Chapter 182: Clear Cell Carcinoma 214. Chapter 183: Benign Brenner Tumor 215. Chapter 184: Proliferating/Borderline Brenner Tumor 216. Chapter 185: Malignant Brenner Tumor 217. Chapter 186: Transitional Cell Carcinoma (Non-Brenner Type) 218. Chapter 187: Small Cell Carcinoma, Hypercalcemic Type 219. Chapter 188: Small Cell Carcinoma, Pulmonary Type 220. Chapter 189: Large Cell Neuroendocrine Carcinoma 221. Chapter 190: Hepatoid Carcinoma 222. MIXED EPITHELIAL-STROMAL TUMORS 223. Chapter 191: Mesodermal Adenosarcoma 224. Chapter 192: Malignant Mixed Mesodermal Tumor 225. STROMAL AND SEX CORD TUMORS 226. Chapter 193: Fibromatous Neoplasms 227. Chapter 194: Thecoma 228. Chapter 195: Sclerosing Stromal Tumor 229. Chapter 196: Microcystic Stromal Tumor 230. Chapter 197: Signet Ring Stromal Tumor 231. Chapter 198: Adult Granulosa Cell Tumor 232. Chapter 199: Juvenile Granulosa Cell Tumor 233. Chapter 200: Sertoli-Leydig Cell Tumor 234. Chapter 201: Sertoli Cell Tumor 235. Chapter 202: Leydig Cell Tumor 236. Chapter 203: Stromal Luteoma 237. Chapter 204: Steroid Cell Tumor, Not Otherwise Specified 238. Chapter 205: Sex Cord Tumor With Annular Tubules 239. Chapter 206: Sex Cord-Stromal Tumor, Not Otherwise Specified 240. MESENCHYMAL TUMORS 241. Chapter 207: Smooth Muscle Tumors 242. Chapter 208: Low-Grade Endometrioid Stromal Sarcoma 243. GERM CELL TUMORS 244. Chapter 209: Dysgerminoma 245. Chapter 210: Yolk Sac Tumor 246. Chapter 211: Polyembryoma 247. Chapter 212: Nongestational Choriocarcinoma 248. Chapter 213: Immature Teratoma 249. Chapter 214: Mature Cystic Teratoma 250. Chapter 215: Struma Ovarii 251. Chapter 216: Strumal Carcinoid 252. Chapter 217: Carcinoid Tumor (Insular, Trabecular, and Mucinous) 253. Chapter 218: Secondary Tumors in Teratomas 254. Chapter 219: Primitive Neuroectodermal Tumor 255. MIXED GERM CELL-STROMAL TUMORS 256. Chapter 220: Gonadoblastoma 257. Chapter 221: Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor 258. MISCELLANEOUS PRIMARY TUMORS 259. Chapter 222: Malignant Mesothelioma 260. Chapter 223: Melanoma 261. Chapter 224: Lymphomas and Leukemias 262. METASTATIC/SECONDARY TUMORS 263. Chapter 225: Colorectal Carcinoma 264. Chapter 226: Gastric Carcinoma 265. Chapter 227: Appendiceal Tumors 266. Chapter 228: Pancreaticobiliary Adenocarcinoma 267. Chapter 229: Lung Carcinoma 268. Chapter 230: Cervical Carcinoma 269. Chapter 231: Uterine Corpus Carcinoma 270. Chapter 232: Breast Carcinoma 271. Chapter 233: Melanoma 272. Chapter 234: Involvement by Gastrointestinal Stromal Tumor 273. SECTION 7: PERITONEUM 274. NONNEOPLASTIC LESIONS 275. Chapter 235: Benign Müllerian Lesions 276. Chapter 236: Florid Mesothelial Hyperplasia 277. Chapter 237: Peritoneal Inclusion Cysts 278. NEOPLASMS 279. Chapter 238: Serous Borderline Tumor 280. Chapter 239: Serous Carcinoma 281. Chapter 240: Well-Differentiated Papillary Mesothelioma 282. Chapter 241: Malignant Mesothelioma 283. Chapter 242: Solitary Fibrous Tumor 284. Chapter 243: Disseminated Peritoneal Leiomyomatosis 285. Chapter 244: Extragastrointestinal Stromal Tumor 286. Chapter 245: Intraabdominal Desmoplastic Small Round Cell Tumor 287. Chapter 246: Pseudomyxoma Peritonei 288. INDEX
No hay muestra disponible
No hay ficha técnica disponible
Part of the highly regarded Diagnostic Pathology series, this updated volume by Drs. Marisa R. Nucci and Esther Oliva is an ideal point-of-care reference for the accurate diagnosis of the full range of nonneoplastic and neoplastic conditions of the female genital tract, including common and uncommon entities. Concise, focused chapters, supported by tables, diagrams, and photographs, keep you up to date with evolving changes in the understanding of the pathobiology of common gynecologic tumors. This revised edition is ideal for pathologists at all levels of experience and training for use as a quick reference and as an efficient review to improve knowledge and skills.
1. Cover image 2. Title page 3. Table of Contents 4. Copyright 5. Dedications 6. Contributing Authors 7. Preface 8. Acknowledgments 9. Sections 10. SECTION 1: VULVA 11. INFLAMMATORY DISORDERS 12. Chapter 1: Lichen Planus 13. Chapter 2: Fixed Drug Eruption 14. Chapter 3: Erythema Multiforme 15. Chapter 4: Plasmacytosis Mucosae (Zoon) 16. Chapter 5: Lichen Sclerosus 17. Chapter 6: Allergic Contact Dermatitis 18. Chapter 7: Psoriasis 19. Chapter 8: Lichen Simplex Chronicus 20. Chapter 9: Foreign Body Granulomas 21. Chapter 10: Verruciform Xanthoma 22. Chapter 11: Crohn Disease 23. Chapter 12: Epidermolytic Hyperkeratosis 24. Chapter 13: Papular Acantholytic Dermatosis 25. Chapter 14: Behçet Disease 26. Chapter 15: Pemphigus 27. Chapter 16: Bullous Pemphigoid 28. Chapter 17: Cicatricial Pemphigoid 29. Chapter 18: Herpes Gestationis 30. Chapter 19: Linear IgA Disease 31. Chapter 20: Herpes Simplex Virus 32. Chapter 21: Syphilis 33. Chapter 22: Chancroid 34. Chapter 23: Molluscum Contagiosum 35. Chapter 24: Dermatophytosis 36. Chapter 25: Candidiasis 37. Chapter 26: Scabetic Infestations 38. Chapter 27: Hidradenitis Suppurativa 39. NONNEOPLASTIC LESIONS 40. Chapter 28: Bartholin and Other Cysts 41. Chapter 29: Endometriosis 42. Chapter 30: Fibroepithelial Stromal Polyp 43. Chapter 31: Massive Edema 44. CUTANEOUS NEOPLASIA 45. Chapter 32: HPV-Related Lesions (Excluding Vulvar Intraepithelial Neoplasia) 46. Chapter 33: Vulvar Intraepithelial Neoplasia 47. Chapter 34: Squamous Cell Carcinoma 48. Chapter 35: Basal Cell Carcinoma 49. Chapter 36: Mucosal Melanotic Macule 50. Chapter 37: Common Melanocytic Nevus 51. Chapter 38: Atypical Nevus of Genital Tract 52. Chapter 39: Malignant Melanoma 53. Chapter 40: Extramammary Paget Disease 54. Chapter 41: Bartholin Gland Carcinoma 55. Chapter 42: Hidradenoma Papilliferum 56. Chapter 43: Fibroadenoma and Phyllodes Tumor 57. Chapter 44: Syringoma 58. Chapter 45: Mixed Tumor 59. Chapter 46: Microcystic Adnexal Carcinoma 60. Chapter 47: Eccrine Spiradenoma 61. Chapter 48: Trichofolliculoma 62. Chapter 49: Trichoepithelioma 63. Chapter 50: Sebaceous Hyperplasia 64. Chapter 51: Sebaceous Carcinoma 65. SOFT TISSUE NEOPLASIA 66. Chapter 52: Angiomyofibroblastoma 67. Chapter 53: Cellular Angiofibroma 68. Chapter 54: Prepubertal Vulval Fibroma 69. Chapter 55: Superficial Angiomyxoma 70. Chapter 56: Deep (Aggressive) Angiomyxoma 71. Chapter 57: Smooth Muscle Tumors 72. Chapter 58: Solitary Fibrous Tumor 73. Chapter 59: Dermatofibrosarcoma Protuberans 74. Chapter 60: Epithelioid Sarcoma 75. Chapter 61: Granular Cell Tumor 76. SECTION 2: VAGINA 77. INFLAMMATORY CONDITIONS 78. Chapter 62: Desquamative Inflammatory Vaginitis 79. Chapter 63: Ligneous Vaginitis 80. Chapter 64: Malakoplakia 81. NONNEOPLASTIC LESIONS 82. Chapter 65: Vaginal Cysts 83. Chapter 66: Adenosis 84. Chapter 67: Polyps 85. Chapter 68: Fallopian Tube Prolapse 86. NEOPLASMS 87. Chapter 69: Vaginal Intraepithelial Neoplasia 88. Chapter 70: Squamous Cell Carcinoma 89. Chapter 71: Adenocarcinomas, Nonclear Cell Type 90. Chapter 72: Clear Cell Carcinoma 91. Chapter 73: Mixed Tumor 92. Chapter 74: Rhabdomyoma 93. Chapter 75: Malignant Melanoma 94. Chapter 76: Yolk Sac Tumor 95. Chapter 77: Secondary Neoplasms 96. SECTION 3: UTERINE CERVIX 97. NONNEOPLASTIC LESIONS 98. Chapter 78: Cervical Infections 99. Chapter 79: Atrophy 100. Chapter 80: Transitional Cell Metaplasia 101. Chapter 81: Immature Squamous Metaplasia 102. Chapter 82: Tubal and Tuboendometrioid Metaplasia 103. Chapter 83: Arias-Stella Reaction 104. Chapter 84: Deciduosis 105. Chapter 85: Endometriosis 106. Chapter 86: Tunnel Clusters 107. Chapter 87: Microglandular Hyperplasia 108. Chapter 88: Deep Glands and Cysts 109. Chapter 89: Endocervical Glandular Hyperplasia (Diffuse and Lobular) 110. Chapter 90: Endocervical Polyp 111. Chapter 91: Ectopic Prostate 112. Chapter 92: Mesonephric Remnants/Hyperplasia 113. Chapter 93: Endocervicosis 114. NEOPLASMS 115. Chapter 94: Squamous Intraepithelial Lesion/Dysplasia 116. Chapter 95: Squamous Cell Carcinoma 117. Chapter 96: Adenocarcinoma In Situ, Including Variants 118. Chapter 97: Usual-Type Adenocarcinoma 119. Chapter 98: Minimal Deviation Adenocarcinoma 120. Chapter 99: Villoglandular Adenocarcinoma 121. Chapter 100: Gastric- and Intestinal-Types Adenocarcinoma, Including Signet Ring Cell Carcinoma 122. Chapter 101: Endometrioid Adenocarcinoma 123. Chapter 102: Clear Cell Adenocarcinoma 124. Chapter 103: Serous Adenocarcinoma 125. Chapter 104: Mesonephric Adenocarcinoma 126. Chapter 105: Adenosquamous Carcinoma, Including Glassy Cell Carcinoma 127. Chapter 106: Adenoid Basal Carcinoma 128. Chapter 107: Adenoid Cystic Carcinoma 129. Chapter 108: Neuroendocrine Tumors 130. Chapter 109: Endocervical-Type Adenomyoma 131. Chapter 110: Müllerian Papilloma 132. Chapter 111: Müllerian Adenosarcoma 133. Chapter 112: Malignant Mixed Müllerian Tumor 134. Chapter 113: Rhabdomyosarcoma 135. Chapter 114: Lymphomas and Leukemias of Lower Genital Tract 136. Chapter 115: Metastatic/Secondary Tumors 137. SECTION 4: UTERINE CORPUS 138. NONNEOPLASTIC LESIONS 139. Chapter 116: Endometritis 140. Chapter 117: Endometrial Metaplasias 141. Chapter 118: Endometrial Polyp 142. NEOPLASMS 143. Chapter 119: Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia 144. Chapter 120: Endometrioid Adenocarcinoma and Variants 145. Chapter 121: Mucinous Adenocarcinoma 146. Chapter 122: Serous Adenocarcinoma 147. Chapter 123: Clear Cell Adenocarcinoma 148. Chapter 124: Squamous Cell Carcinoma 149. Chapter 125: Neuroendocrine Carcinoma 150. Chapter 126: Undifferentiated Carcinoma 151. Chapter 127: Leiomyoma and Variants 152. Chapter 128: Intravenous Leiomyomatosis 153. Chapter 129: Leiomyosarcoma 154. Chapter 130: Perivascular Epithelioid Cell (PEC) Proliferations 155. Chapter 131: Inflammatory Myofibroblastic Tumor 156. Chapter 132: Benign and Low-Grade Endometrial Stromal Tumors 157. Chapter 133: High-Grade Endometrial Stromal Sarcoma 158. Chapter 134: Uterine Tumors Resembling Ovarian Sex Cord Tumors 159. Chapter 135: Undifferentiated Uterine Sarcoma 160. Chapter 136: Adenomatoid Tumor 161. Chapter 137: Endometrioid-Type Adenomyoma 162. Chapter 138: Atypical Polypoid Adenomyoma 163. Chapter 139: Müllerian Adenosarcoma 164. Chapter 140: Malignant Mixed Müllerian Tumor 165. Chapter 141: Rhabdomyosarcoma 166. Chapter 142: Primitive Neuroectodermal Tumor, Peripheral and Central Types 167. Chapter 143: Wilms Tumor 168. Chapter 144: Alveolar Soft Part Sarcoma 169. Chapter 145: Germ Cell Tumors 170. Chapter 146: Lymphoma and Leukemia 171. Chapter 147: Metastatic/Secondary Tumors 172. SECTION 5: FALLOPIAN TUBE AND BROAD LIGAMENT 173. NONNEOPLASTIC LESIONS 174. Chapter 148: Metaplasias 175. Chapter 149: Pseudocarcinomatous Hyperplasia 176. Chapter 150: Salpingitis 177. Chapter 151: Endometriosis 178. NEOPLASMS 179. Chapter 152: Metaplastic Papillary Tumor 180. Chapter 153: Adenomatoid Tumor 181. Chapter 154: Female Adnexal Tumor of Probable Wolffian Origin 182. Chapter 155: Serous Borderline Tumor 183. Chapter 156: Serous Carcinoma, Including Serous Tubal Intraepithelial Carcinoma (STIC) 184. Chapter 157: Endometrioid Adenocarcinoma 185. Chapter 158: Transitional Cell Carcinoma 186. SECTION 6: OVARY 187. NONNEOPLASTIC LESIONS 188. Chapter 159: Follicular Cysts 189. Chapter 160: Stromal Hyperplasia and Hyperthecosis 190. Chapter 161: Pregnancy Luteoma 191. Chapter 162: Hyperreactio Luteinalis 192. Chapter 163: Large Solitary Luteinized Follicle Cyst of Pregnancy 193. Chapter 164: Torsion 194. Chapter 165: Endometriosis and Deciduosis 195. Chapter 166: Massive Edema and Fibromatosis 196. Chapter 167: Autoimmune Oophoritis 197. Chapter 168: Luteinized Thecoma With Sclerosing Peritonitis 198. NEOPLASMS 199. EPITHELIAL TUMORS 200. Chapter 169: Benign Serous Tumors 201. Chapter 170: Serous Borderline Tumor 202. Chapter 171: Low-Grade Serous Adenocarcinoma 203. Chapter 172: High-Grade Serous Adenocarcinoma 204. Chapter 173: Benign Endometrioid Tumors 205. Chapter 174: Endometrioid Borderline Tumor 206. Chapter 175: Endometrioid Adenocarcinoma 207. Chapter 176: Benign Mucinous Tumors 208. Chapter 177: Mucinous Borderline Tumor, Intestinal Type 209. Chapter 178: Mucinous Borderline Tumor, Endocervical Type 210. Chapter 179: Mucinous Adenocarcinoma 211. Chapter 180: Mucinous Cystic Tumor With Mural Nodules 212. Chapter 181: Borderline Clear Cell Adenofibroma 213. Chapter 182: Clear Cell Carcinoma 214. Chapter 183: Benign Brenner Tumor 215. Chapter 184: Proliferating/Borderline Brenner Tumor 216. Chapter 185: Malignant Brenner Tumor 217. Chapter 186: Transitional Cell Carcinoma (Non-Brenner Type) 218. Chapter 187: Small Cell Carcinoma, Hypercalcemic Type 219. Chapter 188: Small Cell Carcinoma, Pulmonary Type 220. Chapter 189: Large Cell Neuroendocrine Carcinoma 221. Chapter 190: Hepatoid Carcinoma 222. MIXED EPITHELIAL-STROMAL TUMORS 223. Chapter 191: Mesodermal Adenosarcoma 224. Chapter 192: Malignant Mixed Mesodermal Tumor 225. STROMAL AND SEX CORD TUMORS 226. Chapter 193: Fibromatous Neoplasms 227. Chapter 194: Thecoma 228. Chapter 195: Sclerosing Stromal Tumor 229. Chapter 196: Microcystic Stromal Tumor 230. Chapter 197: Signet Ring Stromal Tumor 231. Chapter 198: Adult Granulosa Cell Tumor 232. Chapter 199: Juvenile Granulosa Cell Tumor 233. Chapter 200: Sertoli-Leydig Cell Tumor 234. Chapter 201: Sertoli Cell Tumor 235. Chapter 202: Leydig Cell Tumor 236. Chapter 203: Stromal Luteoma 237. Chapter 204: Steroid Cell Tumor, Not Otherwise Specified 238. Chapter 205: Sex Cord Tumor With Annular Tubules 239. Chapter 206: Sex Cord-Stromal Tumor, Not Otherwise Specified 240. MESENCHYMAL TUMORS 241. Chapter 207: Smooth Muscle Tumors 242. Chapter 208: Low-Grade Endometrioid Stromal Sarcoma 243. GERM CELL TUMORS 244. Chapter 209: Dysgerminoma 245. Chapter 210: Yolk Sac Tumor 246. Chapter 211: Polyembryoma 247. Chapter 212: Nongestational Choriocarcinoma 248. Chapter 213: Immature Teratoma 249. Chapter 214: Mature Cystic Teratoma 250. Chapter 215: Struma Ovarii 251. Chapter 216: Strumal Carcinoid 252. Chapter 217: Carcinoid Tumor (Insular, Trabecular, and Mucinous) 253. Chapter 218: Secondary Tumors in Teratomas 254. Chapter 219: Primitive Neuroectodermal Tumor 255. MIXED GERM CELL-STROMAL TUMORS 256. Chapter 220: Gonadoblastoma 257. Chapter 221: Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor 258. MISCELLANEOUS PRIMARY TUMORS 259. Chapter 222: Malignant Mesothelioma 260. Chapter 223: Melanoma 261. Chapter 224: Lymphomas and Leukemias 262. METASTATIC/SECONDARY TUMORS 263. Chapter 225: Colorectal Carcinoma 264. Chapter 226: Gastric Carcinoma 265. Chapter 227: Appendiceal Tumors 266. Chapter 228: Pancreaticobiliary Adenocarcinoma 267. Chapter 229: Lung Carcinoma 268. Chapter 230: Cervical Carcinoma 269. Chapter 231: Uterine Corpus Carcinoma 270. Chapter 232: Breast Carcinoma 271. Chapter 233: Melanoma 272. Chapter 234: Involvement by Gastrointestinal Stromal Tumor 273. SECTION 7: PERITONEUM 274. NONNEOPLASTIC LESIONS 275. Chapter 235: Benign Müllerian Lesions 276. Chapter 236: Florid Mesothelial Hyperplasia 277. Chapter 237: Peritoneal Inclusion Cysts 278. NEOPLASMS 279. Chapter 238: Serous Borderline Tumor 280. Chapter 239: Serous Carcinoma 281. Chapter 240: Well-Differentiated Papillary Mesothelioma 282. Chapter 241: Malignant Mesothelioma 283. Chapter 242: Solitary Fibrous Tumor 284. Chapter 243: Disseminated Peritoneal Leiomyomatosis 285. Chapter 244: Extragastrointestinal Stromal Tumor 286. Chapter 245: Intraabdominal Desmoplastic Small Round Cell Tumor 287. Chapter 246: Pseudomyxoma Peritonei 288. INDEX
No hay muestra disponible
No hay ficha técnica disponible
